132
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Dissemination of Fusidic Acid Resistance Among Staphylococcus epidermidis Clinical Isolates in Wenzhou, China

, &
Pages 2537-2544 | Published online: 17 May 2022

References

  • Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27(4):870–926. doi:10.1128/CMR.00109-13
  • Otto M. Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol. 2012;34(2):201–214. doi:10.1007/s00281-011-0296-2
  • Onishi M, Urushibara N, Kawaguchiya M, et al. Prevalence and genetic diversity of arginine catabolic mobile element (ACME) in clinical isolates of coagulase-negative staphylococci: identification of ACME type I variants in Staphylococcus epidermidis. Infect Genet Evol. 2013;20:381–388. doi:10.1016/j.meegid.2013.09.018
  • Wang JL, Tang HJ, Hsieh PH, et al. Fusidic acid for the treatment of bone and joint infections caused by methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2012;40(2):103–107. doi:10.1016/j.ijantimicag.2012.03.010
  • Schofer H, Simonsen L. Fusidic acid in dermatology: an updated review. Eur J Dermatol. 2010;20(1):6–15. doi:10.1684/ejd.2010.0833
  • Whitby M. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 1999;12(Suppl 2):S67–71. doi:10.1016/S0924-8579(98)00075-2
  • Martins A, Cunha Mde L. Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects. Microbiol Immunol. 2007;51(9):787–795. doi:10.1111/j.1348-0421.2007.tb03968.x
  • Farrell DJ, Castanheira M, Chopra I. Characterization of global patterns and the genetics of fusidic acid resistance. Clin Infect Dis. 2011;52(Suppl 7):S487–92. doi:10.1093/cid/cir164
  • O’Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother. 2007;51(5):1737–1740. doi:10.1128/aac.01542-06
  • O’Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol. 2006;59(2):664–676. doi:10.1111/j.1365-2958.2005.04971.x
  • Chen HJ, Tsai JC, Hung WC, Tseng SP, Hsueh PR, Teng LJ. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates. Antimicrob Agents Chemother. 2011;55(12):5842–5849. doi:10.1128/AAC.00592-11
  • McLaws F, Chopra I, O’Neill AJ. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother. 2008;61(5):1040–1043. doi:10.1093/jac/dkn071
  • Widerstrom M, Wistrom J, Sjostedt A, Monsen T. Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis. 2012;31(1):7–20. doi:10.1007/s10096-011-1270-6
  • Miragaia M, Thomas JC, Couto I, Enright MC, de Lencastre H. Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J Bacteriol. 2007;189(6):2540–2552. doi:10.1128/JB.01484-06
  • Du X, Zhu Y, Song Y, et al. Molecular analysis of Staphylococcus epidermidis strains isolated from community and hospital environments in China. PLoS One. 2013;8(5):e62742. doi:10.1371/journal.pone.0062742
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement (M100-S24). Clinical and Laboratory Standards Institute; 2014.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement (M100-S24). Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2014.
  • Chen HJ, Hung WC, Tseng SP, Tsai JC, Hsueh PR, Teng LJ. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2010;54(12):4985–4991. doi:10.1128/AAC.00523-10
  • Li T, Song Y, Zhu Y, Du X, Li M. Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China. BMC Microbiol. 2013;13(1):153. doi:10.1186/1471-2180-13-153
  • Chongtrakool P, Ito T, Ma XX, et al. Staphylococcal Cassette Chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother. 2006;50(3):1001–1012. doi:10.1128/aac.50.3.1001-1012.2006
  • McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41(11):5113–5120. doi:10.1128/jcm.41.11.5113-5120.2003
  • Chen HJ, Chang YC, Tsai JC, et al. New structure of phage-related islands carrying fusB and a virulence gene in fusidic acid-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother. 2013;57(11):5737–5739. doi:10.1128/aac.01433-13
  • Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res. 2009;164(4):404–410. doi:10.1016/j.micres.2007.03.004
  • McLaws FB, Larsen AR, Skov RL, Chopra I, O’Neill AJ. Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55(3):1173–1176. doi:10.1128/AAC.00817-10
  • Hung WC, Chen HJ, Lin YT, et al. Skin commensal staphylococci may act as reservoir for fusidic acid resistance genes. PLoS One. 2015;10(11):e0143106. doi:10.1371/journal.pone.0143106
  • Sharma P, Satorius AE, Raff MR, Rivera A, Newton DW, Younger JG. Multilocus sequence typing for interpreting blood isolates of Staphylococcus epidermidis. Interdiscip Perspect Infect Dis. 2014;2014:787458. doi:10.1155/2014/787458
  • Mertens A, Ghebremedhin B. Genetic determinants and biofilm formation of clinical Staphylococcus epidermidis isolates from blood cultures and indwelling devises. Eur J Microbiol Immunol. 2013;3(2):111–119. doi:10.1556/EuJMI.3.2013.2.4
  • Mendes RE, Deshpande LM, Costello AJ, Farrell DJ. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals. Antimicrob Agents Chemother. 2012;56(9):4656–4661. doi:10.1128/AAC.00279-12
  • Brenciani A, Morroni G, Pollini S, et al. Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy. J Antimicrob Chemother. 2016;71(2):307–313. doi:10.1093/jac/dkv341
  • Martinez-Melendez A, Morfin-Otero R, Villarreal-Trevino L, et al. Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23. Braz J Infect Dis. 2016;20(5):419–428. doi:10.1016/j.bjid.2016.05.007